The goal (or purpose) of this study is to evaluate (study) a new way to stabilize (steady)
the activity between the fat deposits surrounding the heart and the left atrium.
To reduce the amount of EAT, this study will use a medication called Liraglutide. This
medication is known to work on fat deposits and produce weight loss. The investigator is
conducting this study to find out if Liraglutide will reduce the fat deposits surrounding the
participant's heart, and stabilize (and perhaps reduce or eliminate) atrial fibrillation
activity.